ALPHA FOODS - BEAUTY COLLAGEN
Food supplement declared in France, declaration No 2024-3-638, decision dated 12 March 2024
ALPHA FOODS - BEAUTY COLLAGEN, from Alpha Foods BV, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Bambusa bambos 133 mg per day, Collagène hydrolysé, Elastine, Hyaluronate de sodium, Hydrolysat de kératine. None of the rules we check flags an issue with its declared composition.
- Brand
- ALPHA FOODS
- Food business operator placing the product on the market
- Alpha Foods BV
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Powder
- Daily dose
- 1 cuillère doseuse (15 g) par jour
- Intended populations
- Men, Women
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Pregnant women
- Objectives stated by the manufacturer (these are not authorised claims)
- Skin, Hair and nails
Declaration 139990, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Bambusa bambos (L.) Voss | Jeune pousse | Extrait fluide hydroalcoolique | 133 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Collagène hydrolysé | not declared |
| Elastine | not declared |
| Hyaluronate de sodium | not declared |
| Hydrolysat de kératine | not declared |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Les compléments alimentaires ne doivent pas remplacer un régime alimentaire varié et équilibré et un mode de vie sain. Ne pas dépasser la dose journalière recommandée, Déconseillé aux femmes enceintes. Tenir hors de la portée des jeunes enfants. Si vous prenez des médicaments, consultez votre médecin. Non destiné aux personnes de moins de 18 ans.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Collagène hydrolysé
Read the warning, when it applies and the studies cited
Hydrolyzed Collagen
Route of administration: Oral
Cautions and warnings
Condition of application: Joint pain.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
Applies to products providing more than 2.8 g hydrolyzed collagen, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Shils et al. 2006; Goldman and Ausiello 2004).
Sources cited by Health Canada (2)
- Goldman L, Ausiello D, editors. Cecil Textbook of Medicine, Volume 1, 22nd edition. Philadelphia (PA): Saunders; 2004.
- Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ, editors. Modern Nutrition in Health and Disease, 10th edition. Philadelphia (PA): Lippincott Williams and Wilkins, 2006.
Known adverse reactions
When using this product you may experience gastrointestinal discomfort/disturbances (Moskowitz 2000).
Sources cited by Health Canada (1)
- Moskowitz RW. Role of collagen hydrolysate in bone and joint disease. Seminars in Arthritis and Rheumatism 2000;30(2):87-99. PubMed Randomised trial
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : ALPHA FOODS
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “ALPHA FOODS - BEAUTY COLLAGEN: composition and regulation”, https://compoatlas.com/en/supplements/products/139990-alpha-foods-beauty-collagen, updated 15 November 2026.